ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0813
0.02%
Brent Oil
72.72
0.00%
Bitcoin
97,249.99
-0.52%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Dechra Pharmaceuticals Plc (DPH)

  7. Dechra Pharmaceuticals Plc (DPH) Noticias

DPH

Dechra Pharmaceuticals (DPH)

Dechra Pharmaceuticals Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:DPH
FechaHoraFuenteTítuloSímboloCompañía
17/01/202402:15UK RegulatoryDechra Pharmaceuticals PLC Cancellation of listing and admission to tradingLSE:DPHDechra Pharmaceuticals Plc
17/01/202402:00UK RegulatoryLondon Stock Exchange Notice Cancellation - Dechra Pharmaceuticals PlcLSE:DPHDechra Pharmaceuticals Plc
17/01/202401:30UK RegulatoryDechra Pharmaceuticals PLC Holding(s) in CompanyLSE:DPHDechra Pharmaceuticals Plc
16/01/202409:29UK RegulatoryCredit Industriel et Commercial Form 8.3 - Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
16/01/202409:25UK RegulatoryMILLENNIUM PARTNERS: Form 8.3 - Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
16/01/202407:31UK RegulatoryNATIXIS: Form 8.3 - Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
16/01/202407:25UK RegulatoryState Street Global Advisors Form 8.3 - Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
16/01/202407:15UK RegulatoryBarclays PLC Form 8.3 - Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
16/01/202407:02UK RegulatoryRathbone Brothers Form 8.3 - Dechra Pharmaceuticals PlcLSE:DPHDechra Pharmaceuticals Plc
16/01/202406:50UK RegulatoryMorgan Stanley & Co. Int'l plc Form 8.5 (EPT/RI)-Replacement of DechraLSE:DPHDechra Pharmaceuticals Plc
16/01/202406:44UK RegulatoryBNP Paribas London Form 8.3 - Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
16/01/202404:15UK RegulatoryDechra Pharmaceuticals PLC Scheme of Arrangement becomes EffectiveLSE:DPHDechra Pharmaceuticals Plc
16/01/202404:12UK RegulatoryBank of America Merrill Lynch Form 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PLCLSE:DPHDechra Pharmaceuticals Plc
16/01/202404:11UK RegulatoryBank of America Merrill Lynch Form 8.5 (EPT/RI)LSE:DPHDechra Pharmaceuticals Plc
16/01/202403:20UK RegulatorySociete Generale SA Form 8.3 - Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
16/01/202403:04UK RegulatoryMorgan Stanley & Co. Int'l plc Form 8.5 (EPT/RI)-Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
16/01/202402:30Alliance NewsAlliance NewsIN BRIEF: Dechra shares suspended from trading as takeover completesLSE:DPHDechra Pharmaceuticals Plc
16/01/202402:12UK RegulatoryJefferies International Limited. Form 8.5 (EPT/NON-RI) Dechra Pharmaceuticals PlcLSE:DPHDechra Pharmaceuticals Plc
16/01/202401:39UK RegulatoryInvestec Bank plc Form 8.5 (EPT/RI) - Dechra Pharmaceuticals PlcLSE:DPHDechra Pharmaceuticals Plc
16/01/202401:30UK RegulatoryOfficial List Suspension - Dechra Pharmaceuticals PLCLSE:DPHDechra Pharmaceuticals Plc
15/01/202410:51UK RegulatoryDechra Pharmaceuticals PLC Director/PDMR ShareholdingLSE:DPHDechra Pharmaceuticals Plc
15/01/202409:40UK RegulatoryMELQART ASSET MGMT: Form 8.3 - Dechra Phartmaceuticals PLC - AmendmentLSE:DPHDechra Pharmaceuticals Plc
15/01/202409:30UK RegulatoryForm 8.3 - Dechra Pharmaceuticals PlcLSE:DPHDechra Pharmaceuticals Plc
15/01/202409:20UK RegulatoryBlackRock Group Form 8.3 - Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
15/01/202409:15UK RegulatoryMELQART ASSET MGMT: Form 8.3 - Dechra Pharmaceuticals PLCLSE:DPHDechra Pharmaceuticals Plc
15/01/202409:03UK RegulatoryTIG Advisors, LLC Form 8.3 - Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
15/01/202407:46UK RegulatoryForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
15/01/202406:05UK RegulatoryBank of Nova Scotia Form 8.3 - Dechra Pharmaceuticals plcLSE:DPHDechra Pharmaceuticals Plc
15/01/202403:58UK RegulatoryBank of America Merrill Lynch Form 8.5 (EPT/NON-RI)LSE:DPHDechra Pharmaceuticals Plc
12/01/202410:02UK RegulatoryDechra Pharmaceuticals PLC Court sanction of Scheme of ArrangementLSE:DPHDechra Pharmaceuticals Plc
 Showing the most relevant articles for your search:LSE:DPH

Su Consulta Reciente

USOTC
BNPQY
BNP Paribas (QX)
USOTC
RHHBY
Roche (QX)
CCOM
OILBRENT
Brent Oil
NASDAQ
TSLA
Tesla
FX
USDMXN
US Dollar vs MXN
NYSE
NKE
Nike
COIN
ETHUSD
Ethereum
COIN
SOLUSD
Solana
NASDAQ
MSFT
Microsoft
NYSE
MCD
McDonalds
AMEX
SPY
SPDR S&P 500
NASDAQ
AAPL
Apple
NYSE
CVX
Chevron
COIN
DOGEUSD
Dogecoin
FX
EURMXN
Euro vs MXN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados